Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months

por Mordant, Francesca L., Price, Olivia H., Rudraraju, Rajeev, Slavin, Monica A., Marshall, Caroline, Worth, Leon J., Peck, Heidi, Barr, Ian G., Sullivan, Sheena G., Subbarao, Kanta
Publicado 2022

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques

por Tan, Hyon-Xhi, Juno, Jennifer A., Lee, Wen Shi, Barber-Axthelm, Isaac, Kelly, Hannah G., Wragg, Kathleen M., Esterbauer, Robyn, Amarasena, Thakshila, Mordant, Francesca L., Subbarao, Kanta, Kent, Stephen J., Wheatley, Adam K.
Publicado 2021

Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia

por Toh, Zheng Quan, Higgins, Rachel A., Do, Lien Anh Ha, Rautenbacher, Karin, Mordant, Francesca L., Subbarao, Kanta, Dohle, Kate, Nguyen, Jill, Steer, Andrew C., Tosif, Shidan, Crawford, Nigel W., Mulholland, Kim, Licciardi, Paul V.
Publicado 2021

Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection

por Chang, Jessie J.-Y., Gleeson, Josie, Rawlinson, Daniel, De Paoli-Iseppi, Ricardo, Zhou, Chenxi, Mordant, Francesca L., Londrigan, Sarah L., Clark, Michael B., Subbarao, Kanta, Stinear, Timothy P., Coin, Lachlan J. M., Pitt, Miranda E.
Publicado 2022

Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection

por Chang, Jessie J.-Y., Rawlinson, Daniel, Pitt, Miranda E., Taiaroa, George, Gleeson, Josie, Zhou, Chenxi, Mordant, Francesca L., De Paoli-Iseppi, Ricardo, Caly, Leon, Purcell, Damian F.J., Stinear, Timothy P., Londrigan, Sarah L., Clark, Michael B., Williamson, Deborah A., Subbarao, Kanta, Coin, Lachlan J.M.
Publicado 2021

Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomise...

por Chappell, Keith J., Mordant, Francesca L., Amarilla, Alberto A., Modhiran, Naphak, Liang, Benjamin, Li, Zheyi, Wijesundara, Danushka K., Lackenby, Julia A., Griffin, Paul, Bennet, Jillian K., Hensen, Luca, Zhang, Wuji, Nguyen, Thi H.O., Tran, Mai H., Tapley, Peter, Barnes, James, Reading, Patrick C., Kedzierska, Katherine, Ranasinghe, Charani, Subbarao, Kanta, Watterson, Daniel, Young, Paul R., Munro, Trent P.
Publicado 2023

Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay

por Lopez, Ester, Haycroft, Ebene R., Adair, Amy, Mordant, Francesca L., O’Neill, Matthew T., Pymm, Phillip, Redmond, Samuel J., Lee, Wen Shi, Gherardin, Nicholas A., Wheatley, Adam K., Juno, Jennifer A., Selva, Kevin J., Davis, Samantha K., Grimley, Samantha L., Harty, Leigh, Purcell, Damian F.J., Subbarao, Kanta, Godfrey, Dale I., Kent, Stephen J., Tham, Wai-Hong, Chung, Amy W.
Publicado 2021

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

por Wheatley, Adam K., Juno, Jennifer A., Wang, Jing J., Selva, Kevin J., Reynaldi, Arnold, Tan, Hyon-Xhi, Lee, Wen Shi, Wragg, Kathleen M., Kelly, Hannah G., Esterbauer, Robyn, Davis, Samantha K., Kent, Helen E., Mordant, Francesca L., Schlub, Timothy E., Gordon, David L., Khoury, David S., Subbarao, Kanta, Cromer, Deborah, Gordon, Tom P., Chung, Amy W., Davenport, Miles P., Kent, Stephen J.
Publicado 2021

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features

por Rowntree, Louise C, Chua, Brendon Y, Nicholson, Suellen, Koutsakos, Marios, Hensen, Luca, Douros, Celia, Selva, Kevin, Mordant, Francesca L, Wong, Chinn Yi, Habel, Jennifer R, Zhang, Wuji, Jia, Xiaoxiao, Allen, Lily, Doolan, Denise L, Jackson, David C, Wheatley, Adam K, Kent, Stephen J, Amanat, Fatima, Krammer, Florian, Subbarao, Kanta, Cheng, Allen C, Chung, Amy W, Catton, Mike, Nguyen, Thi HO, van de Sandt, Carolien E, Kedzierska, Katherine
Publicado 2021

Comparison of Seroconversion in Children and Adults With Mild COVID-19

por Toh, Zheng Quan, Anderson, Jeremy, Mazarakis, Nadia, Neeland, Melanie, Higgins, Rachel A., Rautenbacher, Karin, Dohle, Kate, Nguyen, Jill, Overmars, Isabella, Donato, Celeste, Sarkar, Sohinee, Clifford, Vanessa, Daley, Andrew, Nicholson, Suellen, Mordant, Francesca L., Subbarao, Kanta, Burgner, David P., Curtis, Nigel, Bines, Julie E., McNab, Sarah, Steer, Andrew C., Mulholland, Kim, Tosif, Shidan, Crawford, Nigel W., Pellicci, Daniel G., Do, Lien Anh Ha, Licciardi, Paul V.
Publicado 2022

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

por Wines, Bruce D., Kurtovic, Liriye, Trist, Halina M., Esparon, Sandra, Lopez, Ester, Chappin, Klasina, Chan, Li-Jin, Mordant, Francesca L., Lee, Wen Shi, Gherardin, Nicholas A., Patel, Sheila K., Hartley, Gemma E., Pymm, Phillip, Cooney, James P., Beeson, James G., Godfrey, Dale I., Burrell, Louise M., van Zelm, Menno C., Wheatley, Adam K., Chung, Amy W., Tham, Wai-Hong, Subbarao, Kanta, Kent, Stephen J., Hogarth, P. Mark
Publicado 2022

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

por Wines, Bruce D., Kurtovic, Liriye, Trist, Halina M., Esparon, Sandra, Lopez, Ester, Chappin, Klasina, Chan, Li-Jin, Mordant, Francesca L., Lee, Wen Shi, Gherardin, Nicholas A., Patel, Sheila K., Hartley, Gemma E., Pymm, Phillip, Cooney, James P., Beeson, James G., Godfrey, Dale I., Burrell, Louise M., van Zelm, Menno C., Wheatley, Adam K., Chung, Amy W., Tham, Wai-Hong, Subbarao, Kanta, Kent, Stephen J., Hogarth, P. Mark
Publicado 2023

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

por Tosif, Shidan, Neeland, Melanie R., Sutton, Philip, Licciardi, Paul V., Sarkar, Sohinee, Selva, Kevin J., Do, Lien Anh Ha, Donato, Celeste, Quan Toh, Zheng, Higgins, Rachel, Van de Sandt, Carolien, Lemke, Melissa M., Lee, Christina Y., Shoffner, Suzanne K., Flanagan, Katie L., Arnold, Kelly B., Mordant, Francesca L., Mulholland, Kim, Bines, Julie, Dohle, Kate, Pellicci, Daniel G., Curtis, Nigel, McNab, Sarah, Steer, Andrew, Saffery, Richard, Subbarao, Kanta, Chung, Amy W., Kedzierska, Katherine, Burgner, David P., Crawford, Nigel W.
Publicado 2020

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice

por Pymm, Phillip, Adair, Amy, Chan, Li-Jin, Cooney, James P., Mordant, Francesca L., Allison, Cody C., Lopez, Ester, Haycroft, Ebene R., O’Neill, Matthew T., Tan, Li Lynn, Dietrich, Melanie H., Drew, Damien, Doerflinger, Marcel, Dengler, Michael A., Scott, Nichollas E., Wheatley, Adam K., Gherardin, Nicholas A., Venugopal, Hariprasad, Cromer, Deborah, Davenport, Miles P., Pickering, Raelene, Godfrey, Dale I., Purcell, Damian F. J., Kent, Stephen J., Chung, Amy W., Subbarao, Kanta, Pellegrini, Marc, Glukhova, Alisa, Tham, Wai-Hong
Publicado 2021

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain

por Wheatley, Adam K., Pymm, Phillip, Esterbauer, Robyn, Dietrich, Melanie H., Lee, Wen Shi, Drew, Damien, Kelly, Hannah G., Chan, Li-Jin, Mordant, Francesca L., Black, Katrina A., Adair, Amy, Tan, Hyon-Xhi, Juno, Jennifer A., Wragg, Kathleen M., Amarasena, Thakshila, Lopez, Ester, Selva, Kevin J., Haycroft, Ebene R., Cooney, James P., Venugopal, Hariprasad, Tan, Li Lynn, O Neill, Matthew T., Allison, Cody C., Cromer, Deborah, Davenport, Miles P., Bowen, Richard A., Chung, Amy W., Pellegrini, Marc, Liddament, Mark T., Glukhova, Alisa, Subbarao, Kanta, Kent, Stephen J., Tham, Wai-Hong
Publicado 2021

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

por Chappell, Keith J, Mordant, Francesca L, Li, Zheyi, Wijesundara, Danushka K, Ellenberg, Paula, Lackenby, Julia A, Cheung, Stacey T M, Modhiran, Naphak, Avumegah, Michael S, Henderson, Christina L, Hoger, Kym, Griffin, Paul, Bennet, Jillian, Hensen, Luca, Zhang, Wuji, Nguyen, Thi H O, Marrero-Hernandez, Sara, Selva, Kevin J, Chung, Amy W, Tran, Mai H, Tapley, Peter, Barnes, James, Reading, Patrick C, Nicholson, Suellen, Corby, Stavroula, Holgate, Thomas, Wines, Bruce D, Hogarth, P Mark, Kedzierska, Katherine, Purcell, Damian F J, Ranasinghe, Charani, Subbarao, Kanta, Watterson, Daniel, Young, Paul R, Munro, Trent P
Publicado 2021

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

por Fulford, Thomas S., Van, Huy, Gherardin, Nicholas A., Zheng, Shuning, Ciula, Marcin, Drummer, Heidi E., Redmond, Samuel, Tan, Hyon-Xhi, Boo, Irene, Center, Rob J., Li, Fan, Grimley, Samantha L., Wines, Bruce D., Nguyen, Thi H.O., Mordant, Francesca L., Ellenberg, Paula, Rowntree, Louise C., Kedzierski, Lukasz, Cheng, Allen C., Doolan, Denise L., Matthews, Gail, Bond, Katherine, Hogarth, P. Mark, McQuilten, Zoe, Subbarao, Kanta, Kedzierska, Katherine, Juno, Jennifer A., Wheatley, Adam K., Kent, Stephen J., Williamson, Deborah A., Purcell, Damian F.J., Anderson, David A., Godfrey, Dale I.
Publicado 2021

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine

por Deliyannis, Georgia, Gherardin, Nicholas A., Wong, Chinn Yi, Grimley, Samantha L., Cooney, James P., Redmond, Samuel J., Ellenberg, Paula, Davidson, Kathryn C., Mordant, Francesca L., Smith, Tim, Gillard, Marianne, Lopez, Ester, McAuley, Julie, Tan, Chee Wah, Wang, Jing J., Zeng, Weiguang, Littlejohn, Mason, Zhou, Runhong, Fuk-Woo Chan, Jasper, Chen, Zhi-wei, Hartwig, Airn E., Bowen, Richard, Mackenzie, Jason M., Vincan, Elizabeth, Torresi, Joseph, Kedzierska, Katherine, Pouton, Colin W., Gordon, Tom P., Wang, Lin-fa, Kent, Stephen J., Wheatley, Adam K., Lewin, Sharon R., Subbarao, Kanta, Chung, Amy W., Pellegrini, Marc, Munro, Trent, Nolan, Terry, Rockman, Steven, Jackson, David C., Purcell, Damian F.J., Godfrey, Dale I.
Publicado 2023

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

por Nguyen, Thi H.O., Rowntree, Louise C., Petersen, Jan, Chua, Brendon Y., Hensen, Luca, Kedzierski, Lukasz, van de Sandt, Carolien E., Chaurasia, Priyanka, Tan, Hyon-Xhi, Habel, Jennifer R., Zhang, Wuji, Allen, Lilith F., Earnest, Linda, Mak, Kai Yan, Juno, Jennifer A., Wragg, Kathleen, Mordant, Francesca L., Amanat, Fatima, Krammer, Florian, Mifsud, Nicole A., Doolan, Denise L., Flanagan, Katie L., Sonda, Sabrina, Kaur, Jasveen, Wakim, Linda M., Westall, Glen P., James, Fiona, Mouhtouris, Effie, Gordon, Claire L., Holmes, Natasha E., Smibert, Olivia C., Trubiano, Jason A., Cheng, Allen C., Harcourt, Peter, Clifton, Patrick, Crawford, Jeremy Chase, Thomas, Paul G., Wheatley, Adam K., Kent, Stephen J., Rossjohn, Jamie, Torresi, Joseph, Kedzierska, Katherine
Publicado 2021

Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose boo...

por Nolan, Terry M., Deliyannis, Georgia, Griffith, Maryanne, Braat, Sabine, Allen, Lilith F., Audsley, Jennifer, Chung, Amy W., Ciula, Marcin, Gherardin, Nicholas A., Giles, Michelle L., Gordon, Tom P., Grimley, Samantha L., Horng, Lana, Jackson, David C., Juno, Jennifer A., Kedzierska, Katherine, Kent, Stephen J., Lewin, Sharon R., Littlejohn, Mason, McQuilten, Hayley A., Mordant, Francesca L., Nguyen, Thi H.O., Soo, Vanessa Pac, Price, Briony, Purcell, Damian F.J., Ramanathan, Pradhipa, Redmond, Samuel J., Rockman, Steven, Ruan, Zheng, Sasadeusz, Joseph, Simpson, Julie A., Subbarao, Kanta, Fabb, Stewart A., Payne, Thomas J., Takanashi, Asuka, Tan, Chee Wah, Torresi, Joseph, Wang, Jing Jing, Wang, Lin-Fa, Al-Wassiti, Hareth, Wong, Chinn Yi, Zaloumis, Sophie, Pouton, Colin W., Godfrey, Dale I.
Publicado 2023